Regenobody Holdings

Company profile

Regenobody Holdings company profile

ALL ageing phenomena-tissue deterioration, cancer and propensity to infections-can be interpreted as signs of ageing at the level of somatic stem cells. As the regenerative prowess of a living organism is determined by the ability and potential of its stem cells to replace damaged tissue or worn out cells a living organism is therefore as old as its stem cells. By using the regenerative powers of stem cells, REGENOBODY aims to achieve the goal of halting,slowing or reversing the ageing process by giving the body the cellular energy it needs to continue life and improving the quality of life. As a result of our relationship with RNL BIO Ltd of S. Korea we have access to a world leader in the regeneration of one’s own stem cells and other protocols.